40.4
Indaptus Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
27.2
FY23:
14.0
FY24:
6.62
FY25:
9.31
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.19
FY22:
0.82
FY23:
0.93
FY24:
0.72
FY25:
0
Total assets
Change from FY21 to FY25
millions USD
FY21:
40.6
FY22:
28.1
FY23:
14.9
FY24:
7.34
FY25:
9.31
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
4.60
FY22:
3.43
FY23:
2.77
FY24:
3.39
FY25:
6.16
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.07
FY22:
0
FY23:
0.07
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
35.9
FY22:
24.6
FY23:
12.1
FY24:
3.94
FY25:
3.15
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
40.6
FY22:
28.1
FY23:
14.9
FY24:
7.34
FY25:
9.31
All amounts in millions USD